HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
YOUSIF CAPITAL MANAGEMENT, LLC | 67,446 | $2,432,777 | 0.03% |
Dana Investment Advisors, Inc. | 16,153 | $582,639 | 0.03% |
First Western Trust Bank | 15,795 | $569,726 | 0.03% |
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC | 29,264 | $1,055,552 | 0.03% |
Gotham Asset Management, LLC | 35,953 | $1,296,825 | 0.03% |
Retirement Systems of Alabama | 169,694 | $6,120,863 | 0.03% |
WCM INVESTMENT MANAGEMENT, LLC | 236,368 | $8,639,250 | 0.03% |
HoyleCohen, LLC | 8,100 | $292,167 | 0.03% |
AMALGAMATED BANK | 86,375 | $3,116 | 0.02% |
Joel Isaacson & Co., LLC | 10,462 | $377,364 | 0.02% |
Ensign Peak Advisors, Inc | 338,600 | $12,213,302 | 0.02% |
SEI INVESTMENTS CO | 393,971 | $14,210,456 | 0.02% |
Engineers Gate Manager LP | 18,444 | $665,275 | 0.02% |
Covestor Ltd | 922 | $33 | 0.02% |
Laird Norton Wetherby Wealth Management, LLC | 12,581 | $453,797 | 0.02% |
TOWNSQUARE CAPITAL LLC | 36,226 | $1,306,673 | 0.02% |
CSS LLC/IL | 10,700 | $385,949 | 0.02% |
SYNOVUS FINANCIAL CORP | 60,188 | $2,170,976 | 0.02% |
GABELLI FUNDS LLC | 83,738 | $3,020,430 | 0.02% |
Invesco Ltd. | 2,476,145 | $89,314,551 | 0.02% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.